Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours

BACKGROUND: Cancer is the leading cause of death in older dogs and its prevalence is increasing. There is clearly a need to develop more effective anti-cancer drugs in dogs. SG2000 (SJG-136) is a sequence selective DNA minor groove cross-linking agent. Based on its in vitro potency, the spectrum of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellinas-Gomez, Maria, Spanswick, Victoria J., Paredes-Moscosso, Solange R., Robson, Matthew, Pedley, R. Barbara, Thurston, David E., Baines, Stephen J., Stell, Anneliese, Hartley, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539724/
https://www.ncbi.nlm.nih.gov/pubmed/26282406
http://dx.doi.org/10.1186/s12917-015-0534-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539724/
https://www.ncbi.nlm.nih.gov/pubmed/26282406
http://dx.doi.org/10.1186/s12917-015-0534-2

Ejemplares similares